Finger prick blood testing in Leber hereditary optic neuropathy

Area of Science:

• Genetics
• Ophthalmology
• Molecular Biology

Background:

• Optic atrophy can be caused by genetic factors, including mitochondrial DNA (mtDNA) mutations.
• Leber hereditary optic neuropathy (LHON) is a maternally inherited condition leading to vision loss.
• Identifying specific mtDNA mutations is crucial for diagnosing and understanding LHON.

Purpose of the Study:

• To screen individuals from Australian families with optic atrophy for known Leber hereditary optic neuropathy (LHON) mitochondrial DNA (mtDNA) mutations.
• To evaluate the feasibility of using blood spots for genetic screening of LHON.
• To assess the accessibility, safety, and cost-effectiveness of this screening method.

Main Methods:

• Direct polymerase chain reaction (PCR) amplification was used.
• Blood spots collected on Guthrie cards from 33 unrelated Australian families were analyzed.
• Ten specific single base alterations in mtDNA associated with LHON were targeted.

Main Results:

• The study successfully screened for 10 different LHON-associated mtDNA mutations.
• The blood spot method proved effective for genetic analysis.
• This approach demonstrated ease of access, minimal biohazard risk, and reduced costs.

Conclusions:

• Screening for Leber hereditary optic neuropathy (LHON) mitochondrial DNA (mtDNA) mutations is feasible using blood spots.
• This method provides an accessible, safe, and cost-effective approach for identifying LHON.
• The findings support the utility of this technique in clinical genetic testing for optic atrophy.